Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-02

FDA Approved: TERIFLUNOMIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for the generic Teriflunomide from Aurobindo Pharma Limited under an ANDA. This allows the product to be marketed in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)